E. coli bacteria employ a remarkable survival mechanism against antibiotics, according to research from the University of Cologne and Wageningen University & Research. The bacteria produce an enzyme called beta-lactamase that chemically breaks down beta-lactam antibiotics, rendering them ineffective. Notably, dying bacteria release this enzyme into their environment, protecting the bacterial population as a whole—a phenomenon the researchers term "altruistic cell death."

The research team, led by Professor Joachim Krug and Arjan de Visser investigated two different strains of E. coli in response to beta-lactams, the most widely used class of antibiotics worldwide. The project began when Rotem Gross, first author of the study published in PNAS, observed that bacterial cultures initially died when exposed to the antibiotic but eventually recovered and resumed growth. The team’s investigation revealed the mechanism behind this recovery.

The bacteria use a two-pronged defense approach. Surviving bacteria produce beta-lactamase that remains inside their cells, where it degrades absorbed antibiotic. Dying bacteria, however, release the enzyme into the surrounding culture medium, reducing antibiotic concentration. “Therefore, the death of some of the bacteria contributes significantly to the long-term survival of the population as a whole, which can be interpreted as an example of altruistic collective behavior,” says Krug.

Search Antibodies
Search Now Use our Antibody Search Tool to find the right antibody for your research. Filter
by Type, Application, Reactivity, Host, Clonality, Conjugate/Tag, and Isotype.

The extent of this altruistic behavior varied significantly between the two E. coli strains studied. This variation has important clinical implications. Strains relying more heavily on cell death-mediated defense become more susceptible to beta-lactamase inhibitors, substances designed to circumvent antibiotic resistance. These inhibitors work only in the culture medium and cannot penetrate intact cells, making them effective against populations that depend on released enzyme rather than intracellular degradation.

The findings demonstrate that bacteria mobilize diverse defense mechanisms even under simple laboratory conditions. “We were amazed by the variety of defense mechanisms that the bacteria are able to mobilize even under simple laboratory conditions,” notes Krug. This diversity complicates predictions about antibiotic efficacy in realistic physiological settings.